| Size | Price | Stock | Qty |
|---|---|---|---|
| 500mg |
|
||
| 1g |
|
||
| 5g |
|
||
| Other Sizes |
| ADME/Pharmacokinetics |
Absorption, Distribution and Excretion
…It was previously thought to be metabolically stable. When administered orally to guinea pigs, rabbits, rats, and humans on a diet free of cyclohexylamine, cyclohexylamine is mostly excreted unchanged. Cyclohexylamine…Cyclohexamine formed in the intestines is almost completely absorbed and excreted in the urine, while the absorption rate of cyclohexylamine is only 20-40%. Cyclohexylamine…(14)C-cyclohexylamine, administered intravenously in women undergoing therapeutic abortion via abdominal hysterectomy in early pregnancy, crosses the placenta and disperses in fetal tissues, particularly in the liver, spleen, pancreas, and kidneys. …Maternal blood levels…decline rapidly…indicating very rapid elimination… The maximum daily excretion of cyclohexylamine…is 0.1% to 0.9% of the daily cyclohexylamine intake (5 g); after discontinuation, urinary excretion of cyclohexylamine is unstable and persists for 3-4 days. /Cyclohexylsulfamate/ For more complete data on the absorption, distribution, and excretion of cyclohexylsulfamate (6 types), please visit the HSDB record page. Metabolism/Metabolites /Calcium/ Cyclohexylsulfamate labeled with (35)S or (14)C is excreted almost entirely in its unchanged form from the urine and feces of humans and experimental animals, although trace amounts of cyclohexylamine (0.7% dose) were found in the urine of humans and dogs after oral administration… …Biotransformation in rats…is caused by the gut microbiota. When sodium cyclohexylsulfamate (SO) is administered for a long period, the gut microbiota of humans and animals acquires the ability to metabolize SO to cyclohexylamine. /Sodium Cyclohexylsulfamate/ In rodents, the gut microbes that convert SO to cyclohexylamine are Clostridium; in rabbits, Enterobacter; and in humans, Enterococcus. /Sodium cyclohexylsulfamate/ ……Two groups of weaned rats were fed for 8 months…a diet or…a diet containing 0.1% sodium cyclohexylsulfamate…and then a single dose of (14)C-cyclohexylsulfamate was administered via gastric tube. ...7/11 Rats fed with cyclohexylamine converted cyclohexylamine to cyclohexylamine, accounting for 12-25% of the total (14)C in urine. Two of the urine samples contained trace amounts of dicyclohexylamine… When guinea pigs, rabbits, rats, and humans consumed food containing calcium cyclohexylamine, they developed the ability to convert orally administered cyclohexylamine to cyclohexylamine and its metabolites. Biological half-life ……Intravenous injection of 14(C)-cyclohexylamine into pregnant rats…The half-life of cyclohexylamine is approximately 7 hours. Sodium cyclohexylsulfamate |
|---|---|
| Toxicity/Toxicokinetics |
Effects During Pregnancy and Lactation
◉ Overview of Drug Use During Lactation After maternal ingestion, trace amounts of sodium cyclohexylsulfamate enter breast milk. However, some authors suggest that breastfeeding women should limit their intake of non-nutritive sweeteners, as their effects on nursing infants are unclear. ◉ Effects on Breastfed Infants No published information found as of the revision date. ◉ Effects on Lactation and Breast Milk No published information found as of the revision date. |
| Additional Infomation |
Cyclohexylsulfamic acid (CYSSA) is a sulfamic acid compound with an N-cyclohexyl substituent. It is both a heterologous metabolite in humans and an environmental pollutant. Its function is related to sulfamic acid; it is the conjugate acid of CYSSA esters. CYSSA has been reported in Euglena gracilis, and relevant data are available. Salts and esters of CYSSA are also available. See also: Cyclohexylsulfamic acid esters (note moved here).
|
| Molecular Formula |
C6H13NO3S
|
|---|---|
| Molecular Weight |
179.23732
|
| Exact Mass |
179.062
|
| CAS # |
100-88-9
|
| Related CAS # |
Cyclamic acid sodium;139-05-9;Cyclamic Acid-d11;1215770-73-2
|
| PubChem CID |
7533
|
| Appearance |
Crystalline solid
|
| Density |
1.32g/cm3
|
| Melting Point |
~180 °C (dec.)
|
| Index of Refraction |
1.529
|
| LogP |
2.183
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
4
|
| Rotatable Bond Count |
2
|
| Heavy Atom Count |
11
|
| Complexity |
200
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
O=S(O)(NC1CCCCC1)=O
|
| InChi Key |
HCAJEUSONLESMK-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C6H13NO3S/c8-11(9,10)7-6-4-2-1-3-5-6/h6-7H,1-5H2,(H,8,9,10)
|
| Chemical Name |
cyclohexylsulfamic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O : ≥ 100 mg/mL (~557.91 mM)
DMSO : ~100 mg/mL (~557.91 mM) |
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (13.95 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (13.95 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 5.5791 mL | 27.8956 mL | 55.7911 mL | |
| 5 mM | 1.1158 mL | 5.5791 mL | 11.1582 mL | |
| 10 mM | 0.5579 mL | 2.7896 mL | 5.5791 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.